Free Trial

Insider Selling: Vitalhub (TSE:VHI) Director Sells 150,000 Shares of Stock

Vitalhub logo with Medical background

Key Points

  • Danny Matlow, a director at Vitalhub Corp., sold 150,000 shares of the company's stock, representing a 22.39% decrease in ownership.
  • Following the sale, Matlow holds 520,001 shares valued at approximately C$6.63 million, as the stocks were sold at an average price of C$12.75.
  • Multiple research firms have raised their price targets for Vitalhub, with consensus opinions leading to a target price of C$14.08 and an overall rating of "Buy" for the stock.
  • MarketBeat previews top five stocks to own in November.

Vitalhub Corp. (TSE:VHI - Get Free Report) Director Danny Matlow sold 150,000 shares of Vitalhub stock in a transaction dated Thursday, August 28th. The stock was sold at an average price of C$12.75, for a total value of C$1,912,500.00. Following the completion of the sale, the director owned 520,001 shares of the company's stock, valued at approximately C$6,630,012.75. The trade was a 22.39% decrease in their ownership of the stock.

Vitalhub Price Performance

Shares of Vitalhub stock traded down C$0.10 during trading on Friday, hitting C$11.09. 134,896 shares of the company were exchanged, compared to its average volume of 151,120. The firm has a market capitalization of C$696.78 million, a P/E ratio of 138.63, a price-to-earnings-growth ratio of 1.18 and a beta of 0.93. Vitalhub Corp. has a 1-year low of C$8.30 and a 1-year high of C$14.64. The firm's fifty day moving average price is C$12.67 and its 200 day moving average price is C$11.06.

Analyst Upgrades and Downgrades

VHI has been the subject of several analyst reports. National Bankshares set a C$16.00 target price on Vitalhub and gave the stock an "outperform" rating in a research report on Thursday, August 21st. Scotiabank boosted their target price on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research report on Friday, June 20th. TD Securities boosted their target price on Vitalhub from C$15.00 to C$16.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. Raymond James Financial boosted their target price on Vitalhub from C$14.50 to C$15.00 and gave the stock an "outperform" rating in a research report on Tuesday, August 12th. Finally, National Bank Financial upgraded Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. One research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of C$14.08.

Check Out Our Latest Report on VHI

About Vitalhub

(Get Free Report)

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

Further Reading

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.